Javed Anees · CC0Authorities probing ‘counterfeit’ rabies vaccine, says drug regulator
India's drug regulator is investigating a suspected counterfeit rabies vaccine after vials bearing batch number KE25012 failed a potency test conducted by the Central Drugs Laboratory. The manufacturer has denied producing the 'misbranded' vials. The probe raises concerns over drug quality control and the circulation of substandard or falsely labelled medicines.
Nabka Insight
Drug regulation bodies and vaccine quality failures feature in current affairs and health GK.
Powered by AIKey facts
- Batch KE25012 failed a potency test by the Central Drugs Laboratory
- Drug regulator probing the vaccine as counterfeit/misbranded
- Manufacturer denied producing the vials
Relevant forRailways · SSC · State PSC · UPSC